Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

oxaliplatin

  • You have access
    Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    MASAAKI YAMAMOTO, TAKESHI OMORI, NAOKI SHINNO, HISASHI HARA, YOSUKE MUKAI, TAKAHITO SUGASE, TOMOHIRA TAKEOKA, MANABU MIKAMORI, TAKASHI KANEMURA, SHINICHIRO HASEGAWA, HIROFUMI AKITA, NAOTSUGU HARAGUCHI, JUNICHI NISHIMURA, HIROSHI WADA, CHU MATSUDA, MASAYOSHI YASUI, HIROSHI MIYATA and MASAYUKI OHUE
    Anticancer Research November 2023, 43 (11) 5015-5024; DOI: https://doi.org/10.21873/anticanres.16700
  • You have access
    Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
    SEIJI YAMAMOTO, HIRONORI FUJII, KOTARO MURAYAMA, HIROTOSHI IIHARA, DAICHI WATANABE, YUNAMI YAMADA, RYO KOBAYASHI, SHIGERU KIYAMA, AKITAKA MAKIYAMA, KIMIHIKO URANO, NOBUHISA MATSUHASHI, AKIO SUZUKI and KATSUHIKO MATSUURA
    Anticancer Research November 2023, 43 (11) 5099-5105; DOI: https://doi.org/10.21873/anticanres.16710
  • You have access
    Vitamin C Improves the Inhibitory Effects of Oxaliplatin on HCT-116 Colorectal Cancer Growth and Progression Through Cellular Oxidant Function-associated Cadherin Molecules
    PORNNAPAT CHUSANGNIN, THARATHIP MUANGTHONG, WITCHUDA PAYUHAKRIT, SARAWOOT PALIPOCH and PRASIT SUWANNALERT
    Anticancer Research October 2023, 43 (10) 4461-4472; DOI: https://doi.org/10.21873/anticanres.16641
  • You have access
    Poor Prognosis in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX/CAPOX Therapy Is Predicted by the Presence of Many Poorly Differentiated Clusters
    KAZUHIKO YOSHIMATSU, TEPPEI KONO, MASAYA SATAKE, YOSHITOMO ITO, SHUNICHI SHIOZAWA, HIRONORI TANAKA, MASAHARU HIGASHIDA, TOSHIMASA OKADA, SHUJI ENDO, YOSHINAORI FUJIWARA and TOMIO UENO
    Anticancer Research July 2023, 43 (7) 3235-3240; DOI: https://doi.org/10.21873/anticanres.16497
  • You have access
    Casein Kinase 2α Augments Oxaliplatin Resistance in Colorectal Cancer Cells by Increasing ABCE1 Expression
    CHUL WON YUN, JUN HEE LEE and SANG HUN LEE
    Anticancer Research June 2023, 43 (6) 2519-2525; DOI: https://doi.org/10.21873/anticanres.16419
  • Open Access
    Initial Safety Analysis of CapeOx for Elderly Patients With Advanced Gastric Cancer Patients: A Phase II Trial
    KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA and KENSEI YAMAGUCHI
    Anticancer Research May 2022, 42 (5) 2683-2687; DOI: https://doi.org/10.21873/anticanres.15746
  • You have access
    CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer
    JUN KI HONG, DO YEON KIM, JAE-SIK SHIN, YEA SEONG RYU, JAI-HEE MOON, DONG-IN KOH, SEUL LEE, JINWOO LEE, WON JUN LEE, EUN YOUNG LEE, SOO-A JUNG, SEUNG CHAN KIM, HA NA YU, MI JIN KIM, SEUNG-WOO HONG, SANG SOO PARK, JOONYEE JUNG, SEUNG MI KIM, EUN HO KIM, HONG-RAE JEONG, JI HEE GONG, JIEUN KIM, TAE WON KIM and DONG-HOON JIN
    Anticancer Research April 2022, 42 (4) 1813-1819; DOI: https://doi.org/10.21873/anticanres.15657
  • You have access
    A Phase II Study of Dose-reductive XELOX Plus Bevacizumab in Elderly or Vulnerable Patients With Metastatic Colorectal Cancer (MCSGO-1202)
    AYA KATO, NORIKATSU MIYOSHI, TORU OHTSURU, DAISUKE SAKAI, JUNICHI HASEGAWA, KEN NAKATA, MITSUNOBU IMASATO, TAKESHI KATO, MASAKAZU IKENAGA, TOSHIHIRO KUDO, MITSUYOSHI TEI, YOSHINORI KAGAWA, MAMORU UEMURA, HIDEKAZU TAKAHASHI, TAROH SATOH, MASAKI MORI, TSUNEKAZU MIZUSHIMA, HIROFUMI YAMAMOTO, KOHEI MURATA, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research April 2022, 42 (4) 1859-1865; DOI: https://doi.org/10.21873/anticanres.15662
  • You have access
    Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
    FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI
    Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559
  • You have access
    Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma
    STANISLAS QUESADA, EMMANUELLE SAMALIN, SIMON THEZENAS, LAKHDAR KHELLAF, ANNE MOURREGOT, FABIENNE PORTALES, THIBAULT MAZARD, MARC YCHOU and ANTOINE ADENIS
    Anticancer Research January 2022, 42 (1) 185-193; DOI: https://doi.org/10.21873/anticanres.15472

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire